TD Cowen Positive on Cellebrite (CLBT): 'Well Positioned As AI Provides Next Growth Layer'
Tweet Send to a Friend
TD Cowen analyst Shaul Eyal reiterated a Buy rating and $23.00 price target on Cellebrite (NASDAQ: CLBT).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
